Summary
- Current Price
- AKRO price is unknown, with unknown change on
- Current Price All-Time High
- AKRO price vs all-time high is unknown
- Market Cap
- AKRO market cap is unknown, with unknown 1-year change
- PE Ratio
- AKRO PE ratio is unknown
- Revenue
- AKRO current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for AKRO has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Akero Therapeutics, Inc. |
| Ticker | NASDAQ: AKRO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | akerotx.com |
| Employees | 74 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | - | |
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| N/A | - | |
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.75 | ||
| EPS, 1Y Change | -30.05% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.75 | ||
| EPS Estimate | N/A | -$3.94 |
| EPS Est. Change | N/A | -4.81% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | - | |
| Price Target | - | $57.00 |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.84 | -$2.89 | -1.65% | |
| -$3.95 | -$3.75 | +4.99% | |
| -$3.94 | N/A | -4.81% | |
| -$4.22 | N/A | -12.45% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | - | |
| N/A | - | |
| SMA 200 vs Price | N/A | - |
| N/A | - | |
| SMA 50 vs Price | N/A | - |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$3.75 | ||
| -$18.00K | ||
| - | ||
| -$285.42M | ||
| - | ||
| -$252.06M | ||
| - | ||
| -$285.41M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.05 | ||
| 19.38 | ||
| 19.38 | ||
| - | ||
| - | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $750.11M | ||
| $340.24M | ||
| $825.89M | ||
| $770.38M | ||
| $75.77M | ||
| $39.75M | ||
| $36.12M | ||
| $291.00K | ||
| $9.03M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $252.06M | ||
| $285.41M | ||
| $18.00K | ||
| $0.00 | ||
| $18.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$230.11M | ||
| -$109.71M | ||
| $445.85M | ||
| $0.00 | ||
| -$230.11M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wolfe Research | → | |
| HC Wainwright & Co. | → | |
| Jefferies | → | |
| Canaccord Genuity | → | |
| TD Cowen | ||
| B of A Securities | → | |
| Citigroup | → | |
| HC Wainwright & Co. | → | |
| UBS | → | |
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with AKRO
FAQ
What is the ticker symbol for Akero Therapeutics, Inc.?
The ticker symbol for Akero Therapeutics, Inc. is NASDAQ:AKRO
Does Akero Therapeutics, Inc. pay dividends?
No, Akero Therapeutics, Inc. does not pay dividends
What sector is Akero Therapeutics, Inc. in?
Akero Therapeutics, Inc. is in the Healthcare sector
What industry is Akero Therapeutics, Inc. in?
Akero Therapeutics, Inc. is in the Biotechnology industry
What country is Akero Therapeutics, Inc. based in?
Akero Therapeutics, Inc. is headquartered in United States
When did Akero Therapeutics, Inc. go public?
Akero Therapeutics, Inc. initial public offering (IPO) was on June 20, 2019
Is Akero Therapeutics, Inc. in the S&P 500?
No, Akero Therapeutics, Inc. is not included in the S&P 500 index
Is Akero Therapeutics, Inc. in the NASDAQ 100?
No, Akero Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Akero Therapeutics, Inc. in the Dow Jones?
No, Akero Therapeutics, Inc. is not included in the Dow Jones index
When was Akero Therapeutics, Inc. last earnings report?
Akero Therapeutics, Inc.'s most recent earnings report was on February 27, 2026
When does Akero Therapeutics, Inc. report earnings?
The date for Akero Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- AKRO Official Website akerotx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1744659/000119312525272569/0001193125-25-272569-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1744659/000095017025029514/0000950170-25-029514-index.htm
- AKRO Profile on Yahoo Finance finance.yahoo.com/quote/AKRO
- AKRO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/akro